BusinessProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis ConferenceBy Nasdaq OMXOct 24, 2017, 11:00 AM UTC
BusinessProQR to Present at the Chardan Inaugural Gene Therapy ConferenceBy Nasdaq OMXOct 6, 2017, 11:00 AM UTC
BusinessProQR Announces Positive Top-Line Results from a Phase 1b Study of QR-010 in Subjects with Cystic FibrosisBy Nasdaq OMXSep 25, 2017, 8:00 PM UTC
BusinessProQR Presents in vivo Proof of Concept Data for the Axiomer® RNA Editing Platform TechnologyBy Nasdaq OMXSep 21, 2017, 11:05 AM UTC
BusinessProQR to Present at Two Investor Conferences in SeptemberBy Nasdaq OMXSep 21, 2017, 11:00 AM UTC
BusinessProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott ArmstrongBy Nasdaq OMXAug 28, 2017, 11:00 AM UTC
